BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10434663)

  • 1. [Autosomal dominant ALS].
    Abe K
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):320-2. PubMed ID: 10434663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concurrence of familial ALS with Ribbing's disease].
    Iwasaki Y; Ichikawa Y; Ikeda K
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):343-6. PubMed ID: 10434669
    [No Abstract]   [Full Text] [Related]  

  • 3. RNAi therapy: dominant disease gene gets silenced.
    Xu Z; Xia XG
    Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
    [No Abstract]   [Full Text] [Related]  

  • 4. A shared chromosome-21 haplotype among amyotrophic lateral sclerosis families with the A4V SOD1 mutation.
    Rosen DR
    Clin Genet; 2004 Sep; 66(3):247-50. PubMed ID: 15324326
    [No Abstract]   [Full Text] [Related]  

  • 5. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene.
    Kostrzewa M; Burck-Lehmann U; Müller U
    Hum Mol Genet; 1994 Dec; 3(12):2261-2. PubMed ID: 7881433
    [No Abstract]   [Full Text] [Related]  

  • 6. Superoxide dismutase, oxygen radical metabolism, and amyotrophic lateral sclerosis.
    Patterson D; Warner HR; Fox LM; Rahmani Z
    Mol Genet Med; 1994; 4():79-118. PubMed ID: 7981631
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis and gene therapy.
    Miller TM; Smith RA; Cleveland DW
    Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics of amyotrophic lateral sclerosis].
    Andersen PM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(3):54-63. PubMed ID: 11490451
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.
    de Belleroche J; Orrell R; King A
    J Med Genet; 1995 Nov; 32(11):841-7. PubMed ID: 8592323
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromosomal translocation t(18;21)(q23;q22.1) indicates novel susceptibility loci for frontotemporal dementia with ALS.
    Prudlo J; Alber B; Kalscheuer VM; Roemer K; Martin T; Dullinger J; Sittinger H; Niemann S; Heutink P; Ludolph AC; Ropers HH; Zang K; Meyer T
    Ann Neurol; 2004 Jan; 55(1):134-8. PubMed ID: 14705124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental therapies hold promise for treating amyotrophic lateral sclerosis.
    Friedrich MJ
    JAMA; 2005 Mar; 293(9):1048-9. PubMed ID: 15741517
    [No Abstract]   [Full Text] [Related]  

  • 13. A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis.
    Hayward C; Swingler RJ; Simpson SA; Brock DJ
    Am J Hum Genet; 1996 Nov; 59(5):1165-7. PubMed ID: 8900247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Free radicals as a cause of amyotrophic lateral sclerosis?].
    Ignatius J
    Duodecim; 1993; 109(12):1041-3. PubMed ID: 8062674
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium.
    Aguirre T; Matthijs G; Robberecht W; Tilkin P; Cassiman JJ
    Eur J Hum Genet; 1999 Jul; 7(5):599-602. PubMed ID: 10439968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments.
    Brown RH
    Ann Neurol; 1996 Feb; 39(2):145-6. PubMed ID: 8967744
    [No Abstract]   [Full Text] [Related]  

  • 17. siRNAs meet their match.
    Potash J
    Nat Methods; 2006 Nov; 3(11):876. PubMed ID: 17124734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sporadic amyotrophic lateral sclerosis associated with Asp90Ala CuZn-superoxide dismutase mutations in Russia].
    Skvortsova VI; Limborskaia SA; Slominskiĭ PA; Levitskaia NI; Levitskiĭ GN; Shadrina MI; Kondrat'eva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(1):44-7. PubMed ID: 10666886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial amyotrophic lateral sclerosis showing variable clinical courses with (Leu84-->Val) mutation of Cu/Zn superoxide dismutase].
    Ohnishi A; Miyazaki S; Murai Y; Ueno S; Sakai H
    Rinsho Shinkeigaku; 1996 Mar; 36(3):485-7. PubMed ID: 8741355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.
    Shook SJ; Pioro EP
    Ann Neurol; 2009 Jan; 65 Suppl 1():S10-6. PubMed ID: 19191305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.